follow us:Google+ FacebookLinkedInTwitterRSS Feeds

advertisement

J&J says it sells final stake in Elan for $332M

Source: Bloomberg

Back to Top Comments Print

Latest News

advertisement

Johnson & Johnson sold 25.4 million shares of Elan Corp. ending a relationship started four years ago to develop the Alzheimer's disease drug bapineuzumab.

Continue Reading »»

advertisement

Advanced search
Sponsored by
advertisement
  
  
advertisement
  
  
advertisement
Back to Top